Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Mantle-Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03629873
What this trial is testing

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

Who this might be right for
Lymphoma, Large B-Cell, DiffuseMantle Cell LymphomaPeripheral T Cell Lymphoma+1 more
The First Affiliated Hospital with Nanjing Medical University 69
Testing effectiveness (Phase 2)UnknownNCT02685670
What this trial is testing

Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+19 more
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Not applicableLooking for participantsNCT05506410
What this trial is testing

A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Newly Diagnosed Mantle Cell Lymphoma
Zhengzhou University 100
Testing effectiveness (Phase 2)Study completedNCT01718691
What this trial is testing

Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Who this might be right for
Low-grade B Cell Non-Hodgkin's LymphomaMantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not Indicated
SymBio Pharmaceuticals 70
Testing effectiveness (Phase 2)Looking for participantsNCT06533579
What this trial is testing

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic Leukemia+10 more
Vironexis Biotherapeutics Inc. 32
Testing effectiveness (Phase 2)Ended earlyNCT01578343
What this trial is testing

Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Samsung Medical Center 20
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Early research (Phase 1)Looking for participantsNCT05098613
What this trial is testing

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

Who this might be right for
Non-Hodgkin LymphomaB-cell Non-Hodgkin Lymphoma (B-NHL)Mantle Cell Lymphoma (MCL)+1 more
University of Colorado, Denver 68
Not applicableStudy completedNCT00014482
What this trial is testing

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Who this might be right for
Anxiety DisorderChronic Myeloproliferative DisordersDepression+4 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00080925
What this trial is testing

T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
National Institutes of Health Clinical Center (CC) 20
Testing effectiveness (Phase 2)Ended earlyNCT03229382
What this trial is testing

Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse

Who this might be right for
Mantle Cell Lymphoma
Polish Lymphoma Research Group 1
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT05155215
What this trial is testing

Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma

Who this might be right for
LymphomaLymphoma, Mantle-CellNeoplasms by Histologic Type+2 more
Beijing Immunochina Medical Science & Technology Co., Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT01258998
What this trial is testing

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00006225
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+2 more
Northwestern University
Large-scale testing (Phase 3)Study completedNCT03112174
What this trial is testing

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

Who this might be right for
Mantle-Cell Lymphoma
Pharmacyclics LLC. 366
Not applicableStudy completedNCT04872413
What this trial is testing

Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial

Who this might be right for
Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
M.D. Anderson Cancer Center 1
Early research (Phase 1)Ended earlyNCT05144347
What this trial is testing

Study of XL114 in Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)Mantle Cell Lymphoma (MCL)+2 more
Exelixis 2
Early research (Phase 1)Study completedNCT01786135
What this trial is testing

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Who this might be right for
Burkitt LymphomaLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+2 more
Seagen Inc. 64
Next Page